COMMUNIQUÉS West-GlobeNewswire

Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
11/06/2026
WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the [...]
Crescent Biopharma Announces Grants of Inducement Awards
11/06/2026
WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
11/06/2026
GAITHERSBURG, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive [...]
Treace to Present at the Sidoti Small Cap Conference
11/06/2026
PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/06/2026
CAMBRIDGE, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the [...]
Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
11/06/2026
In a post hoc analysis, patients treated with roxadustat showed a durable and clinically meaningful improvement in transfusion independence (TI) in patients with LR-MDS and high transfusion burden (HTB) compared to [...]
Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
11/06/2026
PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
11/06/2026
LEXINGTON, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that Alfred W. [...]
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
11/06/2026
– Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint – 95% of patients completed five years of treatment COPENHAGEN, Denmark, [...]
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
11/06/2026
Doc Pharma financial profile: approximately $24 million asset base, approximately $6.7 million in average annual revenue and approximately $3.2 million in average annual gross profit. Immediately accretive: expected to [...]
LifeLabs Recognized Once Again by Forbes as One of Canada’s Best Employers for 2026
11/06/2026
Toronto, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce that we have been named as one of Canada’s Best Employers for 2026 by Forbes Canada. This award is determined by an independent survey of [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
11/06/2026
Company Announcement COPENHAGEN, Denmark; June 11, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 15,894 restricted stock units and 15,494 warrants to employees of the [...]
Priority Partners Receives Inaugural “Impact of Excellence Award”
11/06/2026
Living Word Seventh-Day Adventist Church Honors Medicaid Plan’s Commitment to Reducing Food Insecurity and Expanding Health Care Access HANOVER, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Priority Partners, one of Maryland’ [...]
Human Continuum Closes Over $5 Million in Seed Round Funding to Support the Development of its Integrated Exosome-Based Therapeutic Longevity Platform
11/06/2026
Jupiter, F.L., June 11, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”) , a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced that it has closed a [...]
Ally Medical ER Opens Its Doors in Frisco
11/06/2026
Ally Medical Emergency Room is now open in one of Texas’s fastest-growing cities, bringing 24/7 five-star emergency care to Frisco families FRISCO, Texas, June 11, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room [...]
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
11/06/2026
SCOTTSDALE, Ariz., June 11, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
Primeadine® Longevity Supplement Named Wellness Innovation of the Year in the 2026 Mindful Awards
11/06/2026
Oxford Healthspan Recognized for Bringing Spermidine and Longevity Science into the Mainstream Wellness Conversation SHERIDAN, Wyo., June 11, 2026 (GLOBE NEWSWIRE) -- Oxford Healthspan announced today that Primeadine [...]
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
11/06/2026
- Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027 - Azora’s [...]
Novo Nordisk A/S: IT Security incident at Novo Nordisk
11/06/2026
Bagsværd, Denmark, 11 June 2026 – Novo Nordisk A/S has identified an IT security incident involving unauthorised access to a limited number of internal IT systems. Upon learning of the incident, we launched an [...]

Pages